Use of real-world evidence in cancer drug funding decisions in Canada: a qualitative study of stakeholders’ perspectives

BACKGROUND: Real-world evidence (RWE) can provide postmarket data to inform whether funded cancer drugs yield expected outcomes and value for money, but it is unclear how to incorporate RWE into Canadian cancer drug funding decisions. As part of the Canadian Real-World Evidence Value for Cancer Drug...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:CMAJ Open
Main Authors: Clausen, Marc, Mighton, Chloe, Kiflen, Ruhi, Sebastian, Agnes, Dai, Wei Fang, Mercer, Rebecca E., Beca, Jaclyn M., Isaranuwatchai, Wanrudee, Chan, Kelvin K.W., Bombard, Yvonne
Formato: Artigo
Idioma:Inglês
Publicado em: Joule Inc. or its licensors 2020
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7721249/
https://ncbi.nlm.nih.gov/pubmed/33234584
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9778/cmajo.20200118
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados